Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News Analysis
Nature Reviews Drug Discovery 6, 334–335 (1 May 2007) | doi:10.1038/nrd2326
Where now for new drugs for atherosclerosis?
Abstract
Novel drugs for atherosclerosis have taken a hard hit in the past year, making it unlikely that any will make it to market this decade. But lessons learned from these failures might help the development of successful drugs, experts say.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
